Kurt Krejcy
AOP Orphan (Austria)(AT)Hewlett-Packard (Austria)(AT)
Publications by Year
Research Areas
Myeloproliferative Neoplasms: Diagnosis and Treatment, Cardiac electrophysiology and arrhythmias, Lung Cancer Treatments and Mutations, Eosinophilic Disorders and Syndromes, Nitric Oxide and Endothelin Effects
Most-Cited Works
- → Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study(2009)1,114 cited
- → Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study(2020)333 cited
- → Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, Pemetrexed disodium, ALIMTA™ and cisplatin: A multicenter phase II trial(2000)155 cited
- → Sex differences in concentrations of exhaled nitric oxide and plasma nitrate(1996)113 cited
- → Non‐Motor Symptoms in Parkinson's Disease are Reduced by Nabilone(2020)112 cited
- → Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b(2022)106 cited